WAYRILZ

RILZABRUTINIB · Genzyme Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for WAYRILZ, covering 2025-08-29 to 2026-01-08. Get the full timeline:

Most recent: EMA Authorised: Wayrilz (rilzabrutinib) — Sanofi B.V.